Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span

Kevin J. Pearson; Joseph A. Baur; Kaitlyn N. Lewis; Leonid Peshkin; Nathan L. Price; Nazar Labinskyy; William R. Swindell; Davida Kamara; Robin K. Minor; Evelyn Perez; Hamish A. Jamieson; Yongqing Zhang; Stephen R. Dunn; Kumar Sharma; Nancy Pleshko; Laura A. Woollett; Anna Csiszar; Yuji Ikeno; David Le Couteur; Peter J. Elliott; Kevin G. Becker; Placido Navas; Donald K. Ingram; Norman S. Wolf; Zoltan Ungvari; David A. Sinclair; Rafael de Cabo

doi:10.1016/j.cmet.2008.06.011

Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span

Kevin J. Pearson, Joseph A. Baur, Kaitlyn N. Lewis, Leonid Peshkin, Nathan L. Price, Nazar Labinskyy, William R. Swindell, Davida Kamara, Robin K. Minor, Evelyn Perez, Hamish A. Jamieson, Yongqing Zhang, Stephen R. Dunn, Kumar Sharma, Nancy Pleshko, Laura A. Woollett, Anna Csiszar, Yuji Ikeno, David Le Couteur, Peter J. ElliottKevin G. Becker, Placido Navas, Donald K. Ingram, Norman S. Wolf, Zoltan Ungvari, David A. Sinclair, Rafael de Cabo

Research output: Contribution to journal › Article › peer-review

1030 Scopus citations

Abstract

A small molecule that safely mimics the ability of dietary restriction (DR) to delay age-related diseases in laboratory animals is greatly sought after. We and others have shown that resveratrol mimics effects of DR in lower organisms. In mice, we find that resveratrol induces gene expression patterns in multiple tissues that parallel those induced by DR and every-other-day feeding. Moreover, resveratrol-fed elderly mice show a marked reduction in signs of aging, including reduced albuminuria, decreased inflammation, and apoptosis in the vascular endothelium, increased aortic elasticity, greater motor coordination, reduced cataract formation, and preserved bone mineral density. However, mice fed a standard diet did not live longer when treated with resveratrol beginning at 12 months of age. Our findings indicate that resveratrol treatment has a range of beneficial effects in mice but does not increase the longevity of ad libitum-fed animals when started midlife.

Original language	English
Pages (from-to)	157-168
Number of pages	12
Journal	Cell Metabolism
Volume	8
Issue number	2
DOIs	https://doi.org/10.1016/j.cmet.2008.06.011
State	Published - Aug 6 2008

Bibliographical note

Funding Information:
David A. Sinclair declares he is a consultant to Sirtris, a GSK sirtuin company, and a board member/shareholder of Genocea Biosciences, a vaccine company. Peter J. Elliott declares he is a full-time employee and shareholder of GSK/Sirtris. We would like to thank Dawn Phillips for animal care, Hank Rasnow for purchasing the mice, William Wood for microarray assistance, Katie Burke for help with the plasma lipid and lipoprotein cholesterol concentrations, Patrick Loerch for helpful suggestions and advice, and Mark Beasley and David Allison for assistance with Cox Regression Modeling. We would like to thank Steve Sollott, Alexei Sharov, and Dan Longo for critical reading of the manuscript. This work utilized the facilities of the HSS Musculoskeletal Repair and Regeneration Core Center (NIH AR46121) and was supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. D.A.S. is an Ellison Medical Foundation Senior Scholar. This work was supported by grants from the American Heart Association (0425834T to J.A.B. and 0435140N to A.C.) and from the NIH (RO1GM068072, AG19972, and AG19719 to D.A.S.), (HL077256 to Z.U.), (HD034089 to L.W), (2RO1 EY011733 to N.S.W.), Spanish grant (BFU2005-03017 to P.N.), and by the generous support of Mr. Paul F. Glenn and The Paul F. Glenn Laboratories for the Biological Mechanisms of Aging.

Keywords

HUMDISEASE
SYSBIO

ASJC Scopus subject areas

Physiology
Molecular Biology
Cell Biology

Access to Document

10.1016/j.cmet.2008.06.011

Cite this

Pearson, K. J., Baur, J. A., Lewis, K. N., Peshkin, L., Price, N. L., Labinskyy, N., Swindell, W. R., Kamara, D., Minor, R. K., Perez, E., Jamieson, H. A., Zhang, Y., Dunn, S. R., Sharma, K., Pleshko, N., Woollett, L. A., Csiszar, A., Ikeno, Y., Le Couteur, D., ... de Cabo, R. (2008). Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span. Cell Metabolism, 8(2), 157-168. https://doi.org/10.1016/j.cmet.2008.06.011

@article{dff2b9e1baaa4fe19f94ccba6ced24c9,

title = "Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span",

abstract = "A small molecule that safely mimics the ability of dietary restriction (DR) to delay age-related diseases in laboratory animals is greatly sought after. We and others have shown that resveratrol mimics effects of DR in lower organisms. In mice, we find that resveratrol induces gene expression patterns in multiple tissues that parallel those induced by DR and every-other-day feeding. Moreover, resveratrol-fed elderly mice show a marked reduction in signs of aging, including reduced albuminuria, decreased inflammation, and apoptosis in the vascular endothelium, increased aortic elasticity, greater motor coordination, reduced cataract formation, and preserved bone mineral density. However, mice fed a standard diet did not live longer when treated with resveratrol beginning at 12 months of age. Our findings indicate that resveratrol treatment has a range of beneficial effects in mice but does not increase the longevity of ad libitum-fed animals when started midlife.",

keywords = "HUMDISEASE, SYSBIO",

author = "Pearson, {Kevin J.} and Baur, {Joseph A.} and Lewis, {Kaitlyn N.} and Leonid Peshkin and Price, {Nathan L.} and Nazar Labinskyy and Swindell, {William R.} and Davida Kamara and Minor, {Robin K.} and Evelyn Perez and Jamieson, {Hamish A.} and Yongqing Zhang and Dunn, {Stephen R.} and Kumar Sharma and Nancy Pleshko and Woollett, {Laura A.} and Anna Csiszar and Yuji Ikeno and {Le Couteur}, David and Elliott, {Peter J.} and Becker, {Kevin G.} and Placido Navas and Ingram, {Donald K.} and Wolf, {Norman S.} and Zoltan Ungvari and Sinclair, {David A.} and {de Cabo}, Rafael",

note = "Funding Information: David A. Sinclair declares he is a consultant to Sirtris, a GSK sirtuin company, and a board member/shareholder of Genocea Biosciences, a vaccine company. Peter J. Elliott declares he is a full-time employee and shareholder of GSK/Sirtris. We would like to thank Dawn Phillips for animal care, Hank Rasnow for purchasing the mice, William Wood for microarray assistance, Katie Burke for help with the plasma lipid and lipoprotein cholesterol concentrations, Patrick Loerch for helpful suggestions and advice, and Mark Beasley and David Allison for assistance with Cox Regression Modeling. We would like to thank Steve Sollott, Alexei Sharov, and Dan Longo for critical reading of the manuscript. This work utilized the facilities of the HSS Musculoskeletal Repair and Regeneration Core Center (NIH AR46121) and was supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. D.A.S. is an Ellison Medical Foundation Senior Scholar. This work was supported by grants from the American Heart Association (0425834T to J.A.B. and 0435140N to A.C.) and from the NIH (RO1GM068072, AG19972, and AG19719 to D.A.S.), (HL077256 to Z.U.), (HD034089 to L.W), (2RO1 EY011733 to N.S.W.), Spanish grant (BFU2005-03017 to P.N.), and by the generous support of Mr. Paul F. Glenn and The Paul F. Glenn Laboratories for the Biological Mechanisms of Aging. ",

year = "2008",

month = aug,

day = "6",

doi = "10.1016/j.cmet.2008.06.011",

language = "English",

volume = "8",

pages = "157--168",

number = "2",

}

Pearson, KJ, Baur, JA, Lewis, KN, Peshkin, L, Price, NL, Labinskyy, N, Swindell, WR, Kamara, D, Minor, RK, Perez, E, Jamieson, HA, Zhang, Y, Dunn, SR, Sharma, K, Pleshko, N, Woollett, LA, Csiszar, A, Ikeno, Y, Le Couteur, D, Elliott, PJ, Becker, KG, Navas, P, Ingram, DK, Wolf, NS, Ungvari, Z, Sinclair, DA & de Cabo, R 2008, 'Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span', Cell Metabolism, vol. 8, no. 2, pp. 157-168. https://doi.org/10.1016/j.cmet.2008.06.011

TY - JOUR

T1 - Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span

AU - Pearson, Kevin J.

AU - Baur, Joseph A.

AU - Lewis, Kaitlyn N.

AU - Peshkin, Leonid

AU - Price, Nathan L.

AU - Labinskyy, Nazar

AU - Swindell, William R.

AU - Kamara, Davida

AU - Minor, Robin K.

AU - Perez, Evelyn

AU - Jamieson, Hamish A.

AU - Zhang, Yongqing

AU - Dunn, Stephen R.

AU - Sharma, Kumar

AU - Pleshko, Nancy

AU - Woollett, Laura A.

AU - Csiszar, Anna

AU - Ikeno, Yuji

AU - Le Couteur, David

AU - Elliott, Peter J.

AU - Becker, Kevin G.

AU - Navas, Placido

AU - Ingram, Donald K.

AU - Wolf, Norman S.

AU - Ungvari, Zoltan

AU - Sinclair, David A.

AU - de Cabo, Rafael

N1 - Funding Information: David A. Sinclair declares he is a consultant to Sirtris, a GSK sirtuin company, and a board member/shareholder of Genocea Biosciences, a vaccine company. Peter J. Elliott declares he is a full-time employee and shareholder of GSK/Sirtris. We would like to thank Dawn Phillips for animal care, Hank Rasnow for purchasing the mice, William Wood for microarray assistance, Katie Burke for help with the plasma lipid and lipoprotein cholesterol concentrations, Patrick Loerch for helpful suggestions and advice, and Mark Beasley and David Allison for assistance with Cox Regression Modeling. We would like to thank Steve Sollott, Alexei Sharov, and Dan Longo for critical reading of the manuscript. This work utilized the facilities of the HSS Musculoskeletal Repair and Regeneration Core Center (NIH AR46121) and was supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. D.A.S. is an Ellison Medical Foundation Senior Scholar. This work was supported by grants from the American Heart Association (0425834T to J.A.B. and 0435140N to A.C.) and from the NIH (RO1GM068072, AG19972, and AG19719 to D.A.S.), (HL077256 to Z.U.), (HD034089 to L.W), (2RO1 EY011733 to N.S.W.), Spanish grant (BFU2005-03017 to P.N.), and by the generous support of Mr. Paul F. Glenn and The Paul F. Glenn Laboratories for the Biological Mechanisms of Aging.

PY - 2008/8/6

Y1 - 2008/8/6

N2 - A small molecule that safely mimics the ability of dietary restriction (DR) to delay age-related diseases in laboratory animals is greatly sought after. We and others have shown that resveratrol mimics effects of DR in lower organisms. In mice, we find that resveratrol induces gene expression patterns in multiple tissues that parallel those induced by DR and every-other-day feeding. Moreover, resveratrol-fed elderly mice show a marked reduction in signs of aging, including reduced albuminuria, decreased inflammation, and apoptosis in the vascular endothelium, increased aortic elasticity, greater motor coordination, reduced cataract formation, and preserved bone mineral density. However, mice fed a standard diet did not live longer when treated with resveratrol beginning at 12 months of age. Our findings indicate that resveratrol treatment has a range of beneficial effects in mice but does not increase the longevity of ad libitum-fed animals when started midlife.

AB - A small molecule that safely mimics the ability of dietary restriction (DR) to delay age-related diseases in laboratory animals is greatly sought after. We and others have shown that resveratrol mimics effects of DR in lower organisms. In mice, we find that resveratrol induces gene expression patterns in multiple tissues that parallel those induced by DR and every-other-day feeding. Moreover, resveratrol-fed elderly mice show a marked reduction in signs of aging, including reduced albuminuria, decreased inflammation, and apoptosis in the vascular endothelium, increased aortic elasticity, greater motor coordination, reduced cataract formation, and preserved bone mineral density. However, mice fed a standard diet did not live longer when treated with resveratrol beginning at 12 months of age. Our findings indicate that resveratrol treatment has a range of beneficial effects in mice but does not increase the longevity of ad libitum-fed animals when started midlife.

KW - HUMDISEASE

KW - SYSBIO

UR - http://www.scopus.com/inward/record.url?scp=48349144852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48349144852&partnerID=8YFLogxK

U2 - 10.1016/j.cmet.2008.06.011

DO - 10.1016/j.cmet.2008.06.011

M3 - Article

C2 - 18599363

AN - SCOPUS:48349144852

SN - 1550-4131

VL - 8

SP - 157

EP - 168

JO - Cell Metabolism

JF - Cell Metabolism

IS - 2

ER -

Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this